The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMCL.L Regulatory News (MCL)

  • There is currently no data for MCL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/NON-RI) - MILLENNIUM & COPTHORNE HOTELS PLC - Amendment

12 Jun 2019 13:16

FORM 8.5 (EPT/NON-RI) Amendment to Purchase

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY AN

EXEMPT PRINCIPAL TRADER WITHOUT RECOGNISED INTERMEDIARY (“RI”) STATUS (OR WHERE RI STATUS IS NOT APPLICABLE)

Rule 8.5 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Name of exempt principal trader:

BARCLAYS CAPITAL SECURITIES LTD

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

MILLENNIUM & COPTHORNE HOTELS PLC

(c) Name of the party to the offer with which exempt principal trader is connected:

Agapier Investments Limited (a company indirectly and wholly-owned by City Developments Limited)

(d) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

10 June 2019

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state “N/A”

NO

2. POSITIONS OF THE EXEMPT PRINCIPAL TRADER

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security: 30p ordinary
Interests Short Positions
Number (%) Number (%)
(1) Relevant securities owned
and/or controlled: 97,855 0.03% 49,932 0.02%
(2) Cash-settled derivatives:
37,665 0.01% 29 0.00%
(3) Stock-settled derivatives (including options)
and agreements to purchase/sell: 0 0.00% 0 0.00%
(4)
TOTAL: 135,520 0.04% 49,961 0.02%

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

3. DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant Purchase/sale Total number of Highest price per unit Lowest price per unit
security securities paid/received paid/received
30p ordinary Purchase 465,452 6.8000 GBP 6.75 GBP
30p ordinary Sale 390,923 6.8000 GBP 6.75 GBP
(b) Cash-settled derivative transactions
Class of Product Nature of dealing Number of Price per
relevant description reference unit
security securities
30p ordinary CFD Long 568 6.7490 GBP
30p ordinary CFD Short 3,643 6.7505 GBP
30p ordinary CFD Short 71,764 6.7654 GBP

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type

e.g. American, European etc.

Expiry date Option money paid/ received per unit

(ii) Exercise

Class of relevant security Product description

e.g. call option

Exercising/ exercised against Number of securities Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security Nature of dealing

e.g. subscription, conversion

Details Price per unit (if applicable)

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?

NO

Date of disclosure:

12 Jun 2019

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

View source version on businesswire.com: https://www.businesswire.com/news/home/20190612005494/en/

Copyright Business Wire 2019

Date   Source Headline
9th Sep 20217:00 amRNSTrading Update
8th Sep 20216:07 pmRNSResult of Court Meeting and General Meeting
3rd Sep 202110:16 amRNSDirectors/PDMRs Dealings
23rd Aug 20211:00 pmRNSCorrection to Notice of General Meeting
16th Aug 20217:00 amRNSIssue of Equity
13th Aug 20217:01 amRNSTrading Update
13th Aug 20217:00 amRNSProposals for new holding company
22nd Jun 202111:30 amRNSResult of AGM
22nd Jun 20217:00 amRNSTrading Update
16th Jun 20215:05 pmRNSAIM Rule 17 Disclosure
14th May 20219:06 amRNSDirector/PDMR Shareholding
13th May 20212:18 pmRNSAnnual Report and Notice of General Meeting
13th May 20217:00 amRNSPreliminary results
29th Apr 20217:00 amRNSBoard Appointments
28th Apr 20217:00 amRNSChange of Registered Office
11th Mar 20217:00 amRNSDirectorate Change
4th Mar 20217:00 amRNSTrading Update
2nd Mar 20219:00 amRNSMorses Club CEO appointed to Board of CCTA
26th Feb 20214:36 pmRNSPrice Monitoring Extension
26th Feb 20217:00 amRNSDirector/PDMR Shareholding
15th Feb 20217:00 amRNSDirectorate Change
27th Jan 20218:44 amRNSReplacement: Director/PDMR Dealings
25th Jan 202111:38 amRNSDirectors/PDMRs Dealings
13th Jan 20217:00 amRNSIssue of Equity
7th Jan 202110:30 amRNSResult of General Meeting
24th Dec 20209:56 amRNSDirector/PDMR Shareholding
22nd Dec 20209:51 amRNSDirector/PDMR Shareholding
18th Dec 20204:35 pmRNSDirector/PDMR Shareholding
18th Dec 20207:00 amRNSInterim Results
17th Dec 20203:45 pmRNSNotice of Interim Results
10th Dec 202011:05 amRNSRegulatory Approval Received for New CFO
27th Nov 20207:01 amRNSAnnual Report and Accounts
27th Nov 20207:00 amRNSPreliminary results
26th Nov 20207:00 amRNSPublication of FY20 Results
23rd Nov 202010:41 amRNSHolding(s) in Company
5th Oct 20207:00 amRNSAppointment of Chief Financial Officer
22nd Sep 202010:00 amRNSResult of AGM
17th Sep 20207:00 amRNSTrading Update
15th Sep 20204:35 pmRNSPrice Monitoring Extension
27th Aug 20207:00 amRNSReporting Deadline
25th Aug 20204:36 pmRNSPrice Monitoring Extension
19th Aug 20207:00 amRNSNotice of Annual General Meeting
18th Aug 20207:00 amRNSNew Strategic Contract for U Account
14th Aug 202011:40 amRNSHolding(s) in Company
10th Aug 20207:00 amRNSTrading and 2020 Results Update
4th Aug 20207:00 amRNSChange of Adviser
29th Jul 20201:41 pmRNSAIM Rule 17 notification
16th Jul 20207:00 amRNSTrading Update
13th Jul 20207:00 amRNSRe-commencement of Lending to New HCC Customers
30th Jun 20201:56 pmRNSResumption of U Account operations

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.